Is there an optimal dosing regimen for CYC

Is there an optimal dosing regimen for CYC?

  • • Mode of administration of CYC depends on the clinical scenario and clinical judgment.
  • • The two commonly recommended IV regimens are:
    • High dose: Monthly boluses of 0.5–1.0 g/m IV × 6 months
    • Low dose (Euro-Lupus protocol): 500 mg IV every 2 weeks × 6 doses
  • • Low-dose therapy is associated with fewer serious infections and less risk of infertility, but some patients may fail to respond to lower doses
  • • IV dosing regimens (compared with oral) result in a lower total CYC exposure, which is important when considering effects on fertility and bladder toxicity.
  • • Note that the risk of premature ovarian failure correlates with the cumulative dose of CYC (>10–15 g total dose) and the age of the patient (>30 years).
    • • Measurement of anti-Mullerian hormone assesses ovarian reserve can be considered but clinical utility is unclear
  • • For recalcitrant disease, consider rituximab 1 g with CYC 500–750 mg IV followed by the same 14 days later. Response may take months. The CALIBRATE study is investigating this regimen followed by belimumab for Class III/IV nephritis, but the results were not as promising as hoped.

Sign up to receive the trending updates and tons of Health Tips

Join SeekhealthZ and never miss the latest health information

Scroll to Top